Table 4.
Period | PSS | Group C(n = 20) | Group PE(n = 20) | Group PED(n = 20) | P Valuea | |||
---|---|---|---|---|---|---|---|---|
|
||||||||
Number | % | Number | % | Number | % | |||
Discharge | 3 | 15 | 75 | 17 | 85 | 0 | 0 | <0.001** |
4 | 5 | 25 | 3 | 15 | 20 | 100 | ||
Month 6 | 3 | 11 | 55 | 9 | 45 | 2 | 10 | = 0.008*** |
4 | 9 | 45 | 11 | 55 | 18 | 90 |
Group C, Control Group; Group PE, Pre-emptive Epidural Group; Group PED, Pre-emptive Epidural + Dexketoprofen Group.
Data are given as number and %;
PSS score was found to be higher in a statistically significant way in Group PED at the discharge measurement point, compared to the other groups P<0.001;
PSS score was found to be higher in a statistically significant way in Group PED at the sixth-month measurement point, compared to the other groups P<0.05.
Kruskal-wallis test.